Medtronic has begun working with computer chip maker Nvidia on a platform for artificial intelligence applications to run on its medical devices. The companies hope
Sernova Corp has announced that the first two patients in the second cohort of its active U.S. Phase 1/2 clinical trial for the treatment of
Glooko, Inc has announced a new global partnership with Hedia, integrating its technology into Glooko’s diabetes management platforms for healthcare providers and people with diabetes.
In the latest move towards finding a stem cell-based cure for Type 1 diabetes, American company Vertex has announced a new agreement with CRISPR Therapeutics
A recent article in Scientific American is reporting that telehealth is now being used in new medical areas, such as in cancer care in the
Scientists at the University of Sussex have successfully trialed new biodegradable health sensors – such as those worn by runners or patients to monitor heart
Two diabetes management devices that aid in the precision of insulin delivery have been recently cleared by the U.S. Food and Drug Administration (FDA). On
Medtronic has announced that one-year research data backs the use of its next-generation MiniMed 780G automated insulin pump. The ADAPT study, which included 82 adults
Nemaura Medical has announced that it now includes insulin under its DuoPack commercial license agreement. Nemaura Medical entered into a commercial agreement in September 2021
A 13-week trial has found that a hybrid closed-loop automated insulin delivery system improved time-in-range for blood glucose compared with standard care for children with
